Interestingly, as observed in Figures 6A,B, post-vaccination PBMC were able to lyse ≥50% autologous tumor cells in a 10:1 effector: target ratio when they were boosted in vitro with CSF-470 vaccine lysate, probably reflecting stimulation of cytotoxic T cells targeting common/shared TAAs. This evidence concerns the gene CSF2 and neoplasm.